
BSE Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- BSE recorded record quarterly revenues of INR 674.4 crores, up 149% YoY; operational revenues rose 182% to INR 607.7 crores, indicating robust growth momentum.
- Strong contribution from all business lines and product improvements boost confidence in sustained revenue growth.
- Sensex and Bankex derivatives markets have shown record trading volumes and premium turnover, reflecting increasing market participation.
- The surge in retail and institutional participation, with registered investors growing 51% to 18.4 crore, underpins volume growth potential.
- Launch of single stock derivatives with mid-month expiry exceeded expectations, signaling opportunity for segment expansion.
- Emerging regulatory changes (e.g., weekly expiry contracts) introduce uncertainties but also open new growth avenues.
- BSE remains committed to providing a vibrant platform and adapting proactively to regulatory and market dynamics to sustain growth in sales, revenues, and volumes.
See what BSE management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what BSE management said on order book — free account, 30 seconds.
Capex plans
YesTrack BSE — get its next earnings analysis in your feed
How does BSE rank vs peers in Capital Markets?
Pro featureHow does BSE rank in Capital Markets?
Compare BSE against every Capital Markets company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What BSE's management said in earlier quarters
Others in Capital Markets this season
- CARE Ratings Ltd (Q1 FY25)
78.92 Crs, up 19% YoY (Page 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
- ICRA Ltd (Q3 FY25)
Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…
- CARE Ratings Ltd (Q3 FY26)
90.24 Crs, up 15% YoY (Page 12, 2) . Key concall takeaways from CARE Ratings Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- CARE Ratings Ltd (Q1 FY27)
111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.